Novartis to invest US$ 23 bn in US to avoid import tariffs; Pfizer halts development of GLP-1 weight-loss pill
After Eli Lilly and
Johnson & Johnson, Novartis has become the latest big pharma to announce
mega investments in the US. The ...
Impressions : 1197
IRA price talks conclude, three meds dominate savings; Gilead’s Livdelzi from CymaBay buyout gets FDA okay
This week, the Biden-Harris Administration said it has concluded price negotiations for 10 drugs under the Inflation Reduction ...
Impressions : 1122
US Senator seeks “unannounced” FDA inspections; Nektar reports manufacturing issues with lead project
This week in Phispers, we bring you news about Nektar Therapeutics which disclosed declining efficacy of its lead project due t...
Impressions : 2694
High-level exit at Dr. Reddy’s; Drug stockpiling starts as firms face ‘no-deal Brexit’ blues
With Britain preparing for a ‘no-deal Brexit’, Phispers this week looks at how pharmaceutical companies are ex...
Impressions : 3398
- Privacy policy
- Terms and conditions
- Disclaimers
-
- Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.